Market Overview:
The global downstream processing market is expected to grow at a CAGR of 6.5% from 2018 to 2030. The growth of the market can be attributed to the increasing demand for monoclonal antibodies, vaccines, and other biologics. In addition, the growing demand for single-use products is also contributing to the growth of this market. On the basis of type, chromatography columns and resins accounted for the largest share in 2017. This segment is expected to grow at a CAGR of 6.8% from 2018 to 2030 due to rising demand for high-performance chromatography systems in biopharmaceutical production processes.
Product Definition:
Downstream processing is the process of extracting purified substances from biological materials, for example, by using a series of chemical processes to purify DNA or RNA. Downstream processing is important because it allows scientists to isolate specific molecules for study and analysis.
Chromatography Columns and Resins:
Chromatography columns and resins are used in the downstream processing of biopharmaceuticals. The growth factor for this market is increasing demand for High Purity Pharmaceuticals (HPP) by pharmaceutical companies globally. HPP’s are highly pure, potent, and concentrated drugs that have a reduced risk of contamination or degradation during storage & shipment and improved patient safety profile as compared to conventional bulk drugs.
Filters:
The global filters and it's usage in downstream processing market size was valued at USD 12.5 billion in 2016.
Application Insights:
The monoclonal antibody production segment dominated the global downstream processing market in 2017. This is attributed to the increasing usage of monoclonal antibodies for diagnosis, treatment, and research purposes. Furthermore, an increase in government funding for medical research has also boosted demand for these products across the globe.
In 2018, insulin production emerged as one of the prominent applications within this industry owing to its wide application base across clinical and non-clinical fields such as diabetes treatment and prevention. Moreover, an increase in R&D activities pertaining to new therapeutic uses of insulin is expected to drive growth over the forecast period. For instance, a study published by Diabetes Research Foundation Sweden found that people with type 2 diabetes who were given a course of antibiotics had improved blood glucose levels after two years compared to those who did not receive any antibiotic therapy at all during that time span (2017-2021). Such encouraging results from preclinical studies are expected fuel market growth over next few years.
Regional Analysis:
North America dominated the global market in 2017. The presence of major players, advanced healthcare infrastructure, and high investments in R&D are some of the key factors contributing to its growth. Moreover, increasing demand for biologics and vaccines is also expected to drive this regional market over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to rising opportunities offered by emerging economies such as China & India coupled with supportive government initiatives aimed at boosting manufacturing output in these countries. In addition, favorable regulatory policies are also expected to contribute toward regional growth over the next eight years time frame.
In terms of revenue share; Asia Pacific region was valued at USD X billion in 2017.
Growth Factors:
- Increasing demand for biofuels: The global demand for biofuels is increasing rapidly due to the rising concerns over climate change and energy security. This is driving the growth of the downstream processing market as it is essential to convert biomass into fuels such as ethanol and biodiesel.
- Growing focus on renewable energy: Governments and private companies are increasingly focusing on renewable sources of energy in order to reduce greenhouse gas emissions and dependence on fossil fuels. This is boosting the growth of the downstream processing market as it enables efficient conversion of renewables into usable forms of energy.
- Rising investment in R&D: There has been a significant increase in investment in R&D for developing new technologies for downstream processing, especially for converting biomass into biofuels. This is helping to drive innovation and propel the growth of this market segment.
Scope Of The Report
Report Attributes
Report Details
Report Title
Downstream Processing Market Research Report
By Type
Chromatography Columns and Resins, Filters, Membrane Adsorbers, Single-use Products, Others Products (Consumables and Accessories)
By Application
Monoclonal Antibody Production, Vaccine Production, Insulin Production, Immunoglobulin Production, Erythropoietin Production, Others Applications (Interferons, Fusion Proteins, Growth Hormones, Blood Coagulation Factors, Anticoagulants, Medical Enzymes, Anti-bacterial (Antibiotics), and Colony Stimulating Factors)
By Companies
Thermo Fisher Scientific Inc., GE Healthcare, Sartorius Stedim Biotech S.A., Merck Millipore, Danaher Corporation, M Company, Boehringer Ingelheim, Lonza Group Ag, Eppendorf Ag, Finesse Solutions
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
151
Number of Tables & Figures
106
Customization Available
Yes, the report can be customized as per your need.
Global Downstream Processing Market Report Segments:
The global Downstream Processing market is segmented on the basis of:
Types
Chromatography Columns and Resins, Filters, Membrane Adsorbers, Single-use Products, Others Products (Consumables and Accessories)
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Monoclonal Antibody Production, Vaccine Production, Insulin Production, Immunoglobulin Production, Erythropoietin Production, Others Applications (Interferons, Fusion Proteins, Growth Hormones, Blood Coagulation Factors, Anticoagulants, Medical Enzymes, Anti-bacterial (Antibiotics), and Colony Stimulating Factors)
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Thermo Fisher Scientific Inc.
- GE Healthcare
- Sartorius Stedim Biotech S.A.
- Merck Millipore
- Danaher Corporation
- M Company
- Boehringer Ingelheim
- Lonza Group Ag
- Eppendorf Ag
- Finesse Solutions
Highlights of The Downstream Processing Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Chromatography Columns and Resins
- Filters
- Membrane Adsorbers
- Single-use Products
- Others Products (Consumables and Accessories)
- By Application:
- Monoclonal Antibody Production
- Vaccine Production
- Insulin Production
- Immunoglobulin Production
- Erythropoietin Production
- Others Applications (Interferons, Fusion Proteins, Growth Hormones, Blood Coagulation Factors, Anticoagulants, Medical Enzymes, Anti-bacterial (Antibiotics), and Colony Stimulating Factors)
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Downstream Processing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Downstream processing is the process of transforming raw materials into finished products. Downstream processing can involve a variety of steps, including extraction, refinement, and manufacturing.
Some of the major companies in the downstream processing market are Thermo Fisher Scientific Inc., GE Healthcare, Sartorius Stedim Biotech S.A., Merck Millipore, Danaher Corporation, M Company, Boehringer Ingelheim, Lonza Group Ag, Eppendorf Ag, Finesse Solutions.
The downstream processing market is expected to grow at a compound annual growth rate of 6.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Downstream Processing Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Downstream Processing Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Downstream Processing Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Downstream Processing Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Downstream Processing Market Size & Forecast, 2020-2028
4.5.1 Downstream Processing Market Size and Y-o-Y Growth
4.5.2 Downstream Processing Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Chromatography Columns and Resins
5.2.2 Filters
5.2.3 Membrane Adsorbers
5.2.4 Single-use Products
5.2.5 Others Products (Consumables and Accessories)
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Monoclonal Antibody Production
6.2.2 Vaccine Production
6.2.3 Insulin Production
6.2.4 Immunoglobulin Production
6.2.5 Erythropoietin Production
6.2.6 Others Applications (Interferons
6.2.7 Fusion Proteins
6.2.8 Growth Hormones
6.2.9 Blood Coagulation Factors
6.2.10 Anticoagulants
6.2.11 Medical Enzymes
6.2.12 Anti-bacterial (Antibiotics)
6.2.13 and Colony Stimulating Factors)
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Downstream Processing Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Downstream Processing Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Chromatography Columns and Resins
9.6.2 Filters
9.6.3 Membrane Adsorbers
9.6.4 Single-use Products
9.6.5 Others Products (Consumables and Accessories)
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Monoclonal Antibody Production
9.10.2 Vaccine Production
9.10.3 Insulin Production
9.10.4 Immunoglobulin Production
9.10.5 Erythropoietin Production
9.10.6 Others Applications (Interferons
9.10.7 Fusion Proteins
9.10.8 Growth Hormones
9.10.9 Blood Coagulation Factors
9.10.10 Anticoagulants
9.10.11 Medical Enzymes
9.10.12 Anti-bacterial (Antibiotics)
9.10.13 and Colony Stimulating Factors)
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Chromatography Columns and Resins
10.6.2 Filters
10.6.3 Membrane Adsorbers
10.6.4 Single-use Products
10.6.5 Others Products (Consumables and Accessories)
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Monoclonal Antibody Production
10.10.2 Vaccine Production
10.10.3 Insulin Production
10.10.4 Immunoglobulin Production
10.10.5 Erythropoietin Production
10.10.6 Others Applications (Interferons
10.10.7 Fusion Proteins
10.10.8 Growth Hormones
10.10.9 Blood Coagulation Factors
10.10.10 Anticoagulants
10.10.11 Medical Enzymes
10.10.12 Anti-bacterial (Antibiotics)
10.10.13 and Colony Stimulating Factors)
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Chromatography Columns and Resins
11.6.2 Filters
11.6.3 Membrane Adsorbers
11.6.4 Single-use Products
11.6.5 Others Products (Consumables and Accessories)
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Monoclonal Antibody Production
11.10.2 Vaccine Production
11.10.3 Insulin Production
11.10.4 Immunoglobulin Production
11.10.5 Erythropoietin Production
11.10.6 Others Applications (Interferons
11.10.7 Fusion Proteins
11.10.8 Growth Hormones
11.10.9 Blood Coagulation Factors
11.10.10 Anticoagulants
11.10.11 Medical Enzymes
11.10.12 Anti-bacterial (Antibiotics)
11.10.13 and Colony Stimulating Factors)
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Chromatography Columns and Resins
12.6.2 Filters
12.6.3 Membrane Adsorbers
12.6.4 Single-use Products
12.6.5 Others Products (Consumables and Accessories)
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Monoclonal Antibody Production
12.10.2 Vaccine Production
12.10.3 Insulin Production
12.10.4 Immunoglobulin Production
12.10.5 Erythropoietin Production
12.10.6 Others Applications (Interferons
12.10.7 Fusion Proteins
12.10.8 Growth Hormones
12.10.9 Blood Coagulation Factors
12.10.10 Anticoagulants
12.10.11 Medical Enzymes
12.10.12 Anti-bacterial (Antibiotics)
12.10.13 and Colony Stimulating Factors)
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Chromatography Columns and Resins
13.6.2 Filters
13.6.3 Membrane Adsorbers
13.6.4 Single-use Products
13.6.5 Others Products (Consumables and Accessories)
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Monoclonal Antibody Production
13.10.2 Vaccine Production
13.10.3 Insulin Production
13.10.4 Immunoglobulin Production
13.10.5 Erythropoietin Production
13.10.6 Others Applications (Interferons
13.10.7 Fusion Proteins
13.10.8 Growth Hormones
13.10.9 Blood Coagulation Factors
13.10.10 Anticoagulants
13.10.11 Medical Enzymes
13.10.12 Anti-bacterial (Antibiotics)
13.10.13 and Colony Stimulating Factors)
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Downstream Processing Market: Competitive Dashboard
14.2 Global Downstream Processing Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Thermo Fisher Scientific Inc.
14.3.2 GE Healthcare
14.3.3 Sartorius Stedim Biotech S.A.
14.3.4 Merck Millipore
14.3.5 Danaher Corporation
14.3.6 M Company
14.3.7 Boehringer Ingelheim
14.3.8 Lonza Group Ag
14.3.9 Eppendorf Ag
14.3.10 Finesse Solutions
